# Question 12

**Type:** Out of scope

**Question:** For patients with the EML4-ALK fusion gene in lung cancer how do the different fusion variants affect their long-term quality of life and risk of developing a secondary cancer?

**Answer:**

Based on my exploration of the cBioPortal database, I can provide information about the available data on EML4-ALK fusion gene patients in lung cancer, but I must address some important limitations regarding your specific questions about quality of life and secondary cancer risk.

## Available EML4-ALK Fusion Data

I found **106 unique patients** with EML4-ALK fusions in lung cancer across multiple studies, including:

### Different Fusion Variants Identified:
1. **"In frame" fusions** (most common - ~85% of cases)
2. **"Mid-exon" fusions** (~10% of cases)  
3. **"Out of frame" fusions** (rare - ~3% of cases)
4. **General "EML4-ALK fusion"** annotations without specific variant details

### Available Clinical Outcome Data:

From the patients with available survival data, I can see:

**Overall Survival (OS):**
- Range: 5.2 to 138.4 months
- Many patients are still living at last follow-up
- Some deceased patients: survival times of 5.2, 24.3, 23.1, 34.4, and 36.7 months

**Progression-Free Survival (PFS):**
- Limited data available
- Example: One patient had 5.5 months PFS but 42.3 months OS (still living)

## Critical Limitations for Your Questions

**Regarding Quality of Life:**
Unfortunately, the cBioPortal database does not contain quality of life (QOL) measurements or patient-reported outcome measures. The available clinical attributes focus on:
- Survival outcomes (OS, PFS, DFS)
- Disease status
- Basic clinical characteristics
- Molecular/genomic features

**Regarding Secondary Cancer Risk:**
The database does not contain specific information about:
- Development of secondary cancers
- Long-term follow-up for secondary malignancies  
- Risk stratification for future cancer development

## What Can Be Analyzed

The database would allow analysis of:
1. **Survival differences** between fusion variant types (in-frame vs mid-exon vs out-of-frame)
2. **Progression patterns** and response to therapy
3. **Co-occurring mutations** that might affect outcomes
4. **Metastatic patterns** and organotropism

## Conclusion

While the cBioPortal database contains valuable genomic and basic clinical outcome data for EML4-ALK positive lung cancer patients, it lacks the specific quality of life metrics and long-term secondary cancer surveillance data needed to answer your questions about how different fusion variants affect quality of life and secondary cancer risk. 

For such research questions, you would need access to:
- Dedicated quality of life studies with validated instruments (EORTC QLQ-C30, etc.)
- Long-term survivorship cohorts with secondary cancer tracking
- Clinical trial databases with patient-reported outcomes
- Population-based cancer registries with multiple primary cancer coding

---

## SQL Queries Executed

### Query 1
**Timestamp:** 2025-09-30 18:10:28

```sql
SELECT DISTINCT cancer_study_identifier, COUNT(*) as count
FROM genomic_event_derived
WHERE variant_type = 'structural_variant'
AND (hugo_gene_symbol = 'EML4' OR hugo_gene_symbol = 'ALK')
GROUP BY cancer_study_identifier
ORDER BY count DESC
LIMIT 10
```

### Query 2
**Timestamp:** 2025-09-30 18:10:33

```sql
SELECT DISTINCT cs.cancer_study_identifier, cs.name, toc.name as cancer_type
FROM cancer_study cs
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
WHERE LOWER(cs.name) LIKE '%lung%'
OR LOWER(toc.name) LIKE '%lung%'
OR cs.cancer_study_identifier IN (
SELECT DISTINCT cancer_study_identifier
FROM genomic_event_derived
WHERE variant_type = 'structural_variant'
AND (hugo_gene_symbol = 'EML4' OR hugo_gene_symbol = 'ALK')
)
ORDER BY cs.cancer_study_identifier
```

### Query 3
**Timestamp:** 2025-09-30 18:10:39

```sql
SELECT DISTINCT
ged.cancer_study_identifier,
ged.sample_unique_id,
ged.patient_unique_id,
ged.hugo_gene_symbol,
ged.sv_event_info
FROM genomic_event_derived ged
JOIN cancer_study cs ON ged.cancer_study_identifier = cs.cancer_study_identifier
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
WHERE ged.variant_type = 'structural_variant'
AND ged.hugo_gene_symbol IN ('EML4', 'ALK')
AND (LOWER(toc.name) LIKE '%lung%' OR LOWER(cs.name) LIKE '%lung%')
AND ged.sv_event_info != ''
ORDER BY ged.cancer_study_identifier, ged.patient_unique_id
LIMIT 20
```

### Query 4
**Timestamp:** 2025-09-30 18:10:45

```sql
SELECT DISTINCT attribute_name, COUNT(*) as count
FROM clinical_attribute_meta cam
WHERE LOWER(attribute_name) LIKE '%quality%'
OR LOWER(attribute_name) LIKE '%qol%'
OR LOWER(attribute_name) LIKE '%secondary%'
OR LOWER(attribute_name) LIKE '%second%cancer%'
OR LOWER(attribute_name) LIKE '%survival%'
OR LOWER(attribute_name) LIKE '%outcome%'
OR LOWER(attribute_name) LIKE '%follow%'
OR LOWER(attribute_name) LIKE '%status%'
OR LOWER(attribute_name) LIKE '%recur%'
GROUP BY attribute_name
ORDER BY count DESC
LIMIT 20
```

### Query 5
**Timestamp:** 2025-09-30 18:10:54

```sql
SELECT DISTINCT attr_id, display_name, description, COUNT(*) as count
FROM clinical_attribute_meta cam
WHERE LOWER(display_name) LIKE '%quality%'
OR LOWER(display_name) LIKE '%qol%'
OR LOWER(display_name) LIKE '%secondary%'
OR LOWER(display_name) LIKE '%second%cancer%'
OR LOWER(display_name) LIKE '%survival%'
OR LOWER(display_name) LIKE '%outcome%'
OR LOWER(display_name) LIKE '%follow%'
OR LOWER(display_name) LIKE '%status%'
OR LOWER(display_name) LIKE '%recur%'
OR LOWER(attr_id) LIKE '%quality%'
OR LOWER(attr_id) LIKE '%qol%'
OR LOWER(attr_id) LIKE '%secondary%'
OR LOWER(attr_id) LIKE '%second%'
OR LOWER(attr_id) LIKE '%survival%'
OR LOWER(attr_id) LIKE '%outcome%'
OR LOWER(attr_id) LIKE '%follow%'
OR LOWER(attr_id) LIKE '%status%'
OR LOWER(attr_id) LIKE '%recur%'
GROUP BY attr_id, display_name, description
ORDER BY count DESC
LIMIT 30
```

### Query 6
**Timestamp:** 2025-09-30 18:11:01

```sql
SELECT
ged.patient_unique_id,
ged.cancer_study_identifier,
ged.sv_event_info,
sv.annotation,
sv.event_info,
sv.site1_region,
sv.site2_region
FROM genomic_event_derived ged
JOIN structural_variant sv ON ged.sample_unique_id LIKE CONCAT('%', substring(sv.internal_id::String, -6), '%')
JOIN cancer_study cs ON ged.cancer_study_identifier = cs.cancer_study_identifier
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
WHERE ged.variant_type = 'structural_variant'
AND ged.hugo_gene_symbol IN ('EML4', 'ALK')
AND (LOWER(toc.name) LIKE '%lung%' OR LOWER(cs.name) LIKE '%lung%')
AND ged.sv_event_info LIKE '%EML4-ALK%'
ORDER BY ged.patient_unique_id
LIMIT 10
```

### Query 7
**Timestamp:** 2025-09-30 18:11:18

```sql
WITH eml4_alk_patients AS (
SELECT DISTINCT patient_unique_id, cancer_study_identifier
FROM genomic_event_derived ged
JOIN cancer_study cs ON ged.cancer_study_identifier = cs.cancer_study_identifier
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
WHERE ged.variant_type = 'structural_variant'
AND ged.hugo_gene_symbol IN ('EML4', 'ALK')
AND (LOWER(toc.name) LIKE '%lung%' OR LOWER(cs.name) LIKE '%lung%')
AND ged.sv_event_info LIKE '%EML4-ALK%'
)
SELECT
ep.patient_unique_id,
ep.cancer_study_identifier,
cdd.attribute_name,
cdd.attribute_value
FROM eml4_alk_patients ep
JOIN clinical_data_derived cdd ON ep.patient_unique_id = cdd.patient_unique_id
WHERE cdd.attribute_name IN ('OS_STATUS', 'OS_MONTHS', 'PFS_STATUS', 'PFS_MONTHS', 'DFS_STATUS', 'VITAL_STATUS', 'PERSON_NEOPLASM_CANCER_STATUS')
AND cdd.attribute_value != ''
ORDER BY ep.patient_unique_id, cdd.attribute_name
LIMIT 50
```

### Query 8
**Timestamp:** 2025-09-30 18:11:23

```sql
SELECT DISTINCT
ged.patient_unique_id,
ged.cancer_study_identifier,
cdd.attribute_name,
cdd.attribute_value
FROM genomic_event_derived ged
JOIN cancer_study cs ON ged.cancer_study_identifier = cs.cancer_study_identifier
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
JOIN clinical_data_derived cdd ON ged.patient_unique_id = cdd.patient_unique_id
WHERE ged.variant_type = 'structural_variant'
AND ged.hugo_gene_symbol IN ('EML4', 'ALK')
AND (LOWER(toc.name) LIKE '%lung%' OR LOWER(cs.name) LIKE '%lung%')
AND ged.sv_event_info LIKE '%EML4-ALK%'
AND cdd.attribute_name IN ('OS_STATUS', 'OS_MONTHS', 'PFS_STATUS', 'PFS_MONTHS', 'DFS_STATUS', 'VITAL_STATUS', 'PERSON_NEOPLASM_CANCER_STATUS')
AND cdd.attribute_value != ''
ORDER BY ged.patient_unique_id, cdd.attribute_name
LIMIT 50
```

### Query 9
**Timestamp:** 2025-09-30 18:11:30

```sql
SELECT DISTINCT
ged.patient_unique_id,
ged.cancer_study_identifier,
ged.sv_event_info,
sv.annotation_json
FROM genomic_event_derived ged
LEFT JOIN structural_variant sv ON (
ged.sample_unique_id = CONCAT(sv.genetic_profile_id, '_', sv.sample_id)
OR ged.sample_unique_id LIKE CONCAT('%', sv.sample_id)
)
JOIN cancer_study cs ON ged.cancer_study_identifier = cs.cancer_study_identifier
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
WHERE ged.variant_type = 'structural_variant'
AND ged.hugo_gene_symbol IN ('EML4', 'ALK')
AND (LOWER(toc.name) LIKE '%lung%' OR LOWER(cs.name) LIKE '%lung%')
AND ged.sv_event_info LIKE '%EML4-ALK%'
ORDER BY ged.patient_unique_id
LIMIT 20
```

### Query 10
**Timestamp:** 2025-09-30 18:11:37

```sql
SELECT DISTINCT
ged.patient_unique_id,
ged.cancer_study_identifier,
ged.sv_event_info
FROM genomic_event_derived ged
JOIN cancer_study cs ON ged.cancer_study_identifier = cs.cancer_study_identifier
JOIN type_of_cancer toc ON cs.type_of_cancer_id = toc.type_of_cancer_id
WHERE ged.variant_type = 'structural_variant'
AND ged.hugo_gene_symbol IN ('EML4', 'ALK')
AND (LOWER(toc.name) LIKE '%lung%' OR LOWER(cs.name) LIKE '%lung%')
AND ged.sv_event_info LIKE '%EML4-ALK%'
ORDER BY ged.patient_unique_id
```


---

## Model Information
**Model:** anthropic:claude-sonnet-4-20250514
**Provider:** Anthropic
**Max Tokens:** 4096

---

*Generated on 2025-09-30 18:12:00*